Healthcare & Life Sciences Insights
Health Tech Newspaper asked health tech experts to reflect on their learnings this year. Julie Pelta, Director of Business Development at DataArt UK, shared her challenges with online relationship building and discoveries in the area of productivity and people management.
In DataArt’s recent podcast, Daniel Piekarz, SVP, Leader of Healthcare & Life Sciences Practice, discusses the impact of COVID-19 on the clinical trial ecosystem, shift to decentralized trials and use of AI in patient retention....Read More
The outbreak of the novel coronavirus at the beginning of 2020 and its rapid spread across the globe have had a huge impact not only on public health, but on every aspect of life. We’ve had to change the way we interact with each other, the way we travel, do business and go shopping. Healthcare...Read More
DataArt’s recent Healthcare and Life Sciences podcast featured Alexander Khmil, Senior MedTech Solution Consultant and expert in 3D Medical Imaging. We collected the most prominent insights in this post....Read More
Daniel Piekarz, SVP, Leader of Healthcare & Life Sciences Practice, discusses the immediate and long-term impacts Covid-19 pandemic would cause on the health of individuals and the economy at large and how healthcare organizations leverage data and technologies to keep up with the demands of the new...Read More
Blockchain – a short word for distributed ledger technology (DTL) — is a decentralized database that stores a registry of assets, data, and transactions across a network of users. The transaction history is locked in data blocks that are linked together and secured through cryptography. The...Read More
In the last four to six years, companies have been experimenting with new approaches that utilize the latest in artificial intelligence and machine learning technologies to identify new molecules and validate new drugs faster and more efficiently. This article will focus on some of the ways these breakthroughs...Read More
Standing on the Shoulders of Giants: The Art & Science of Machine Learning & AI for Drug Discovery & Repurposing
In Pharmaboardroom, Daniel Piekarz, SVP Healthcare and Life Sciences at DataArt, explores how machine learning and artificial intelligence can play into drug repurposing, potentially providing solutions to the most pressing healthcare concerns of today, including the COVID-19 pandemic.
What is the state of medical imaging today? Conventional CT, X-Ray and MRI technologies have been successfully used by medical professionals. Although effective, these types of medical imaging lack interactivity. Modern technological advancements offer the possibility to make data more interactive, which...Read More
In HCPLive, Daniel Piekarz, SVP of Healthcare & Life Sciences at DataArt, debates whether the COVID-19- related clinical trial standstill will drive the industry towards virtual trials.